Skip to main content
Lirum Therapeutics, Inc. (LRTX)
Lirum Therapeutics will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$10.00 - $12.00
Shares Offered
2,270,000
Deal Size
$24.97M

Lirum Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022
Selling, General & Admin
0.490.12
Research & Development
1.71.78
Operating Expenses
2.191.91
Operating Income
-2.19-1.91
Interest Expense / Income
0.010.01
Other Expense / Income
-4.4-3.84
Pretax Income
2.21.92
Net Income
2.21.92
Net Income Growth
14.70%-
Free Cash Flow
-2.24-0.31
EBITDA
2.211.93
EBIT
2.211.93
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).